查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1138354

全球人工耳蜗市场-2022-2029

Global Cochlear Implants Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

由于人口老龄化和技术进步等因素，人工耳蜗的全球市场正在增长，以提供更大的便利。

预计技术进步和人工耳蜗电池寿命的延长将推动市场增长。

不断增长的老年人口（其中大约三分之一受到听力损失的影响）是推动全球人工耳蜗市场增长的关键因素之一。例如，根据美国人口普查局的数据，全世界约有 8.5% 的人，即 6.17 亿 65 岁以上的人患有听力损失。根据世界卫生组织 (WHO) 2019 年报告，全球约有 4.66 亿人患有致残性听力损失。据估计，到 2050 年，将有超过 9 亿人患有听力损失和残疾。大约 11 亿年轻人（12-35 岁）因在娱乐场所接触噪音而面临听力损失的风险。

根据美国疾病控制与预防中心 (CDC) 的数据，到 2025 年，估计将有 9 亿人患有严重的听力损失。大约有 7200 万人可以从使用人工耳蜗和助听器等听力设备中受益。因此，越来越多的听力障碍者增加了对助听器的需求。

此外，人工耳蜗的技术进步正在增强设备以提供更准确的信号并延长电池寿命。一些製造商正在努力提高人工耳蜗的质量和设计。 FDA 批准的 Nucleus 7 声音处理器是第一款专为 iPhone、iPod 和 iPad 设计的人工耳蜗声音解决方案。它的另一个特点是是目前市场上最小、最轻的耳后型人工耳蜗。

由于成本高且维护要求高，人工耳蜗预计会阻碍市场增长。

与手术相关的风险、人工耳蜗批准的等待期、人工耳蜗的高成本以及维修难度是阻碍市场增长的一些因素。

行业分析

全球人工耳蜗市场根据波特五力、监管分析、供应链分析、定价分析、产品创新和未满足的需求等各种行业因素对市场进行了深入分析。

全球人工耳蜗市场报告提供对大约 45 多个市场数据表、40 多个数字和 180 页的访问。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 老年人听力障碍增加
      • 人工耳蜗的技术进步和电池寿命的延长
    • 限制因素
      • 设备和维护成本高
      • 手术受伤的风险
    • 商机
    • 影响分析

第五章行业分析

  • 波特五力分析
  • 监管分析
  • 供应链分析
  • 定价分析
  • 产品创新
  • 未满足的需求

第 6 章按类型

  • 单侧植入
  • 双侧种植体

第 7 章，最终用户

  • 儿科
  • 成人

第 8 章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 9 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 按类型进行基准测试
  • 值得关注的重点公司列表

第 10 章公司简介

  • Cochlear Ltd.
    • 公司概况
    • 按类型和描述划分的投资组合
    • 主要亮点
    • 财务摘要
  • MED-EL GmbH
  • Oticon Medical AB
  • Advanced Bionics AG
  • Demant A/S
  • Sonova Holding AG
  • Nurotron Biotechnology Co Ltd

第11章 人工耳蜗世界市场-DataM

简介目录
Product Code: DMMD2294

Market Overview

Cochlear Implants Market size was valued US$ 1.4 billion in 2021 and is estimated to reach US$ 2.5 billion by 2029, growing at a CAGR of 7.4% during the forecast period (2022-2029).

A cochlear implant is an electronic device that is surgically implanted that stimulates the cochlear nerve and restores the sense of hearing through transmitting the electrical signals to the brain. People mostly use these implants as a hearing aid with low to high hearing loss.

These cochlear implants consist of two parts, the inside component is embedded across the skin, and the external component is worn at the back of the ear. These implants bypass the non-functioning part of the inner ear and provide electrical stimulation to the nerve fibres present in the cochlea.

Market Dynamics

The global cochlear implant market is growing owing to several factors such as the rising geriatric population, technological advancements in devices to make them convenient for use.

Rising technological advancements and increased battery life of cochlear is expected to drive market growth.

The growing geriatric population, of which approximately one-third of people are affected by disabling hearing loss, is one of the major factors boosting the growth of the cochlear implants market globally. For instance, according to the U.S. Census Bureau, about 8.5% of people worldwide, i.e., 617 million were over age 65 were suffering from hearing loss. Also, according to the World Health Organization (WHO) report 2019, about 466 million people are having disabling hearing loss globally. It is estimated that over 900 million people will have disabling hearing loss by 2050. About 1.1 billion young people (age between 12-35 years) are at risk of hearing loss, owing to exposure to noise in recreational settings.

According to the Centres for Disease Control and Prevention (CDC), an estimated 900 million patients are likely to suffer from severe hearing impairment by 2025. There are approximately 72 million people who could potentially benefit from the use of a hearing device, including a cochlear implant or hearing aid. Hence, rising hearing disorders have increased the demand for hearing aid devices.

Also, the increasing technological advancements in cochlear implants are enhancing the devices to transfer signals more accurately and increase their battery life. Several manufacturers are involved in improving the quality and design of cochlear implants. The FDA-approved Nucleus 7 Sound Processor is the first cochlear implant sound solution made specifically for use with iPhones, iPods, and iPads. It also has the distinction of being the smallest and lightest behind-the-ear cochlear implant currently on the market.

High cost of the device and maintenance is expected to hamper the market growth.

Factors such the risk related to surgery, long awaiting approvals for cochlear implants, the high cost of cochlear implants and difficulty in maintenance are some of the factors hampering the growth of the market.

Industry Analysis

The global cochlear implants market provides in-depth analysis of the market based on various industry factors such as Porter's Five Forces, Regulatory Analysis, Supply Chain Analysis, Pricing Analysis, Product Innovation, Unmet Needs.

Segment Analysis

Bilateral implants segment is expected to hold the largest market share in global cochlear implants market

By type, the cochlear implants market is segmented into unilateral implants and bilateral implants. Among these, unilateral implants accounted for the largest market share, owing to their high demand globally. Unilateral implants are of lower cost compared to bilateral implants. According to some studies, the unilateral cochlear implant is more cost-effective for adults and has several health benefits.

On the other hand, the bilateral implants segment is estimated to grow at the fastest CAGR over the forecast period, owing to its ability to recognize the speech in noise, cost-effectiveness when implanted in children, and rising meningitis cases. Also, some countries offer reimbursement only after bilateral implantation, thus, increases the demand for these devices.

Geographical Analysis

North America region holds the largest market share in the global cochlear implants market

North America is dominating the global cochlear implant market accounted for the largest market share, owing to the developed healthcare system, better awareness among the people, and the presence of major market players in this region. The prevalence of hearing loss in the U.S. affects around 10.6 percent of the population, compared to 12.1 percent of the population in Germany and eight percent of those in Switzerland. According to Johns Hopkins Cochlear Center for Hearing and Public Health, approximately 38.2 million Americans (14.3%) report some degree of hearing loss.

According to the National Institute on Deafness and Other Communication Disorders, approximately one in three people in the United States between the ages of 65 and 74 have hearing loss, and nearly half of those older than 75 have difficulty hearing. The number of adults in the United States above 20 years of age with hearing loss is expected to increase from the expected 44.11 million in 2020 to 73.50 million in 2060. The increase is greater in older adults with an expected 55.4% of the US population above 70 years to suffer from hearing loss to 67.4% in 2060. The development of technologically advanced implants is boosting the growth of the market in this region. For instance, in April 2019, Advanced Bionics received approval from Health Canada for its HiRes Ultra 3D Cochlear Implant. The implant is a pain-free and hassle-free choice for patients undergoing MRI examinations.

Competitive Landscape

The global cochlear implants market is consolidated comprises only a few major players. Most of the major players are based in the US and Europe, as these regions are more developed and better funded for healthcare. Some of the major players in the market include Cochlear Ltd, MED-EL Medical Electronics, Oticon Medical, Advanced Bionics AG, Demant A/S, Sonova, Nurotron Biotechnology Co Ltd, among others.

The key players are adopting various growth strategies such as expansion, mergers & acquisitions, partnerships, product launches, and collaborations which are contributing to the growth of the Cochlear Implant market globally. For instance,

On July 22nd, 2019, MED-EL USA received the U.S. Food and Drug Administration (FDA) approval for its cochlear implant system for single-sided deafness (SSD) and asymmetric hearing loss (AHL). This is the first and only time that cochlear implants have been approved for these indications in the United States.

Key Companies to Watch

Cochlear Ltd.:

Overview: Cochlear is an Australia based medical device company which develops and markets variety of implants such as Nucleus cochlear implant, Baha bona conduction implants and hybrid electro-acoustic implants. It was founded in 1981, headquartered in Sydney, Australia.

Product Portfolio:

Nucleus 24 Cochlear Implant System: This is an implant that impart some hearing sensation to the user via electrical stimulation of auditory nerve. It contains 2 components, internal and external.

Key Developments: In 2019, Cochlear announced world's 1st active osseo-integrated steady state implant, Osia. It utilizes digital piezoelectric stimulation that bypass the damaged areas of hearing system by which sound vibrations directly reaches to cochlea.

The global cochlear implants market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

The companies such as Cochlear and Sensorion evaluates SENS-401 with a cochlear's implant. Cochlear invested about USD 1.8 million (€1.6 million) in shares of Sensorion as a part of this collaboration. In exchange, Cochlear would receive a right of first negotiation for a global license of SENS-401 in patients along with specific cochlear devices.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers:
      • 4.1.1.1. Growing hearing impairment in geriatric population
      • 4.1.1.2. Rising technological advancements and increased battery life of cochlear implants
    • 4.1.2. Restraints:
      • 4.1.2.1. High cost of the device and maintenance
      • 4.1.2.2. Risk of injuries in surgery
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Regulatory Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis
  • 5.5. Product Innovations
  • 5.6. Unmet Needs

6. By Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
    • 6.1.2. Market Attractiveness Index, By Type Segment
  • 6.2. Unilateral Implantation
      • 6.2.1.1. Introduction
      • 6.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 6.3. Bilateral Implantation

7. By End User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 7.1.2. Market Attractiveness Index, By End User Segment
  • 7.2. Pediatrics
      • 7.2.1.1. Introduction
      • 7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Adults

8. By Region

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 8.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.2.5.1. U.S.
      • 8.2.5.2. Canada
      • 8.2.5.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 8.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.3.5.1. Germany
      • 8.3.5.2. U.K.
      • 8.3.5.3. France
      • 8.3.5.4. Italy
      • 8.3.5.5. Spain
      • 8.3.5.6. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.4.5.1. Brazil
      • 8.4.5.2. Argentina
      • 8.4.5.3. Rest of South America
  • 8.5. Asia Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 8.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.5.5.1. China
      • 8.5.5.2. India
      • 8.5.5.3. Japan
      • 8.5.5.4. Australia
      • 8.5.5.5. Rest of Asia Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

9. Competitive Landscape

  • 9.1. Key Developments and Strategies
  • 9.2. Company Share Analysis
  • 9.3. Type Types Benchmarking
  • 9.4. List of Key Companies to Watch

10. Company Profiles

  • 10.1. Cochlear Ltd.
    • 10.1.1. Company Overview
    • 10.1.2. Type Type Portfolio and Description
    • 10.1.3. Key Highlights
    • 10.1.4. Financial Overview
  • 10.2. MED-EL GmbH
  • 10.3. Oticon Medical AB
  • 10.4. Advanced Bionics AG
  • 10.5. Demant A/S
  • 10.6. Sonova Holding AG
  • 10.7. Nurotron Biotechnology Co Ltd

LIST NOT EXHAUSTIVE

11. Global Cochlear Implants Market - DataM

  • 11.1. Appendix
  • 11.2. About Us and End User
  • 11.3. Contact Us